Investigating confounding in network‐based test‐negative design influenza vaccine effectiveness studies—Experience from the DRIVE project

Author:

Stuurman Anke L.12ORCID,Levi Miriam3,Beutels Philippe2,Bricout Hélène4ORCID,Descamps Alexandre5,Dos Santos Gaël6,McGovern Ian7ORCID,Mira‐Iglesias Ainara8ORCID,Nauta Jos9,Torcel‐Pagnon Laurence4,Biccler Jorne1,

Affiliation:

1. P95 Epidemiology and Pharmacovigilance Leuven Belgium

2. Centre for Health Economics Research and Modelling Infectious Diseases, Vaccine and Infectious Disease Institute University of Antwerp Antwerp Belgium

3. Epidemiology Unit, Department of Prevention Tuscany Centre Health Authority Florence Italy

4. Medical Department Sanofi Lyon France

5. Inserm CIC 1417, Assistance Publique Hôpitaux de Paris, Hôpital Cochin Université de Paris Paris France

6. Epidemiology, Value Evidence and Outcomes GSK Wavre Belgium

7. Center or Outcomes Research and Epidemiology, Medical Affairs Seqirus Inc. Cambridge Massachusetts USA

8. Vaccine Research Department Foundation for the Promotion of Health and Biomedical Research of Valencia Region (FISABIO – Public Health) Valencia Spain

9. Department of Innovation & Development, Established Pharmaceuticals Division Abbott Healthcare Products B.V. Weesp The Netherlands

Funder

Innovative Medicines Initiative

European Commission

Horizon 2020 Framework Programme

European Federation of Pharmaceutical Industries and Associations

Publisher

Wiley

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,Pulmonary and Respiratory Medicine,Epidemiology

Reference44 articles.

1. DRIVE consortium. DRIVE – Development of Robust and Innovative Vaccine Effectiveness: Increasing understanding of influenza vaccine effectiveness in Europe.2022.https://www.drive-eu.org/

2. The Use of Test-negative Controls to Monitor Vaccine Effectiveness

3. StuurmanA BollaertsK AlexandridouM et al.D7.4 Setting up brand‐specific influenza vaccine effectiveness studies in Europe – results of the pilot season 2017/18.2018.https://www.drive-eu.org/wp-content/uploads/2018/12/D7_4_Report-pilot-season-201718_v1.0.pdf

4. Vaccine effectiveness against laboratory-confirmed influenza in Europe – Results from the DRIVE network during season 2018/19

5. Brand-specific influenza vaccine effectiveness estimates during 2019/20 season in Europe – Results from the DRIVE EU study platform

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3